For the first time, CD4 cell count determination would be implemented at the community level outside traditional health structures in Sub Saharan Africa. This is important because universal access to anti-retroviral therapy (ARTs) cannot be achieved without a scalable model for early determination of CD4 count at the community level.
In an innovative public-private partnership, the humanitarian aid and development assistance organization CHF International has worked closely with Vestergaard Frandsen both in designing the intervention and organizing the community for its launch. Says CHF's Dr. Eric Lugada, who will track the campaign's results: "CHF International is working with a network of service agencies and community organizations to reduce the impact of HIV/AIDS in Kenya by providing sustainable high-quality, expanded HIV/AIDS services. Vestergaard Frandsen and CHF International is an excellent partnership as CHF International's approach of working from the bottom up, with grass-roots communities, means that the basic care packages will be distributed where they are most needed."
The IPD campaign can be replicated throughout Kenya and around Africa, and represents an important opportunity to meet many of the United Nation's Millennium Development Goals. "This campaign will contribute greatly to our national target of ensuring that 80% of the adult population knows their HIV status by 2010. At the moment only 36% of the Kenyan adult population has been tested at least once. HIV testing is one of the key pillars of HIV prevention and access to treatment, care and support," said Dr. Nicholas Muraguri, the head of Kenya's National AIDS and STI control program (NASCOP).
The population of Lurambi is approximately 113,000 persons. The primary target group for the intervention is women and men aged 15-49 years.
Partners for the IPD campaign includ
|SOURCE Vestergaard Frandsen|
Copyright©2008 PR Newswire.
All rights reserved